RFP NO. ASLM/ACDC/MPOX/DIAG/09/30/25

CLOSING DATE: 31 OCTOBER 2025

When responding to this RFP mention the RFP number in the subject line

Introduction

The African Society for Laboratory Medicine (ASLM) is a Pan‐African professional body, working to advocate for the critical role and needs of laboratory medicine and networks throughout Africa. For more information, please visit our website at https://aslm.org.

The Africa Centres for Disease Control and Prevention (Africa CDC) is the autonomous Health Agency of the African Union (AU) that supports Member States in their efforts to strengthen their health systems. Africa CDC was officially launched in Addis Ababa, Ethiopia, on January 31, 2017, and is guided by the principles of leadership, credibility, and ownership, and delegated authority, timely dissemination of information, transparency, accountability, and value addition. The Africa CDC is Africa’s first continent-wide public health agency and envisions a safer, healthier, integrated, and stronger Africa, where Member States are capable of effectively responding to outbreaks of infectious diseases and other public health threats. For more information, please visit: https://africacdc.org/

The Africa Centres for Disease Control and Prevention (Africa CDC) through the Center for Laboratory Diagnostics and Systems (CLDS) has established the Diagnostic Advisory Committee (DAC) and one of the missions of the DAC is to improve access to In Vitro Diagnostics (IVDs) in Africa by supporting evaluation and recommendation of diagnostic tests for priority diseases. It is in that regard that Africa CDC, in collaboration with the ASLM, invites manufacturers to submit Mpox Rapid Diagnostic Tests (RDTs) and RT-PCR kits for independent evaluation. The goal is to identify high-performing diagnostic tests suitable for use in African contexts and to generate evidence through structured performance studies.

Objectives

• To select local manufacturers with diagnostic tests for mpox to be validated.
• To assist local manufacturers will clinical performance evaluation for consideration in the continental listings by the African Medicines Agency (AMA).

Scope of Products for Submission

Local manufacturers in Africa can submit information about molecular tests and rapid antigen tests for mpox.

Local manufacturers that submit their tests for consideration should meet the following key requirements: